Endpoint definition
↥| Name | LOCALIZED_SKIN_ERUPT_DRUGS_MEDICAM |
|---|---|
| Long name | Localized skin eruption due to drugs and medicaments |
| Hospital Discharge registry | ICD-10: L271 |
| Level in the ICD-hierarchy | C |
| First defined in version | DF5 |
| Name | LOCALIZED_SKIN_ERUPT_DRUGS_MEDICAM |
|---|---|
| Long name | Localized skin eruption due to drugs and medicaments |
| Hospital Discharge registry | ICD-10: L271 |
| Level in the ICD-hierarchy | C |
| First defined in version | DF5 |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 113 | 63 | 50 |
| Unadjusted prevalence (%) | 0.05 | 0.05 | 0.05 |
| Mean age at first event (years) | 54.19 | 53.55 | 55.00 |
| Case fatality at 5-years (%) | 2.65 | 1.59 | 4.00 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | 10.62 | 14.29 | 6.00 |
before Localized skin eruption due to drugs and medicaments
after Localized skin eruption due to drugs and medicaments
Loading survival analyses plot…
Loading survival analyses table…